Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors. | Nat Commun | 2022 | 35440108 | PubTator, text mining | PubMed |
| Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. | Genome Biol | 2022 | 35422018 | PubTator, text mining | PubMed |
| The Role of mTOR and eIF Signaling in Benign Endometrial Diseases. | Int J Mol Sci | 2022 | 35408777 | PubTator, text mining | PubMed |
| miRNAs Contained in Extracellular Vesicles Cargo Contribute to the Progression of Idiopathic Pulmonary Fibrosis: An In Vitro Aproach. | Cells | 2022 | 35406675 | PubTator, text mining | PubMed |
| The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma. | Front Pharmacol | 2022 | 35401175 | PubTator, text mining | PubMed |
| "The emerging role of capivasertib in breast cancer". | Breast | 2022 | 35398754 | PubTator, text mining | PubMed |
| Nintedanib and Dasatinib Treatments Induce Protective Autophagy as a Potential Resistance Mechanism in MPM Cells. | Front Cell Dev Biol | 2022 | 35392170 | PubTator, text mining | PubMed |
| Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control. | J Clin Invest | 2022 | 35380989 | PubTator, text mining | PubMed |
| An amino acid-defined diet impairs tumour growth in mice by promoting endoplasmic reticulum stress and mTOR inhibition. | Mol Metab | 2022 | 35367410 | PubTator, text mining | PubMed |
| Chemical Biology Screening Identifies a Vulnerability to Checkpoint Kinase Inhibitors in TSC2-Deficient Renal Angiomyolipomas. | Front Oncol | 2022 | 35359406 | PubTator, text mining | PubMed |
| Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling. | Cancer Gene Ther | 2022 | 35352024 | PubTator, text mining | PubMed |
| Effect of metformin on proliferative markers in women with endometrial carcinoma: Systematic review and meta-analysis. | Turk J Obstet Gynecol | 2022 | 35343218 | PubTator, text mining | PubMed |
| CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer. | J Clin Med | 2022 | 35329936 | PubTator, text mining | PubMed |
| Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models. | Biomolecules | 2022 | 35327549 | PubTator, text mining | PubMed |
| The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 35326743 | PubTator, text mining | PubMed |
| Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. | Cancers (Basel) | 2022 | 35326659 | PubTator, text mining | PubMed |
| Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas. | Cancers (Basel) | 2022 | 35326631 | PubTator, text mining | PubMed |
| Spreading of Alpha Synuclein from Glioblastoma Cells towards Astrocytes Correlates with Stem-like Properties. | Cancers (Basel) | 2022 | 35326570 | PubTator, text mining | PubMed |
| Occurrence of Total and Proteinase K-Resistant Alpha-Synuclein in Glioblastoma Cells Depends on mTOR Activity. | Cancers (Basel) | 2022 | 35326535 | PubTator, text mining | PubMed |
| Facile discovery of surrogate cytokine agonists. | Cell | 2022 | 35325595 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=23